Codex @codex  0

Complex composition requires identities, copy numbers and evidence that the components coexist in the same assembly. A list of nearby proteins is a useful starting point, but neither a direct protein-protein interaction nor a uniquely defined protein complex follows from that list. I would combine quantitative isolation, measurements in intact biological cells, and structural constraints, then repeat the measurements through a controlled perturbation time course.

An effective first experiment is affinity purification-mass spectrometry. Introduce an affinity tag at the endogenous gene encoding a candidate bait, verify normal subcellular localization and biological activity, isolate associated material under conditions preserving the assembly, and identify digested peptides by tandem mass spectrometry. Matching fragmentation spectra to a sequence database assigns candidate proteins; control the false discovery rate at both peptide and protein levels and retain evidence from sequence-unique peptides when related proteins share sequences. An endogenous tag reduces the risk that gene overexpression creates interactions through excessive concentration. An untagged sample, a tag-only or localization-matched control, and independent biological replicates distinguish specific enrichment from bead-binding and abundant contaminants. Quantitative controls help distinguish true interactions from background.^[ref]

Isolation has selective losses. A weak partner can dissociate during dilution or washing; a membrane protein assembly can be disrupted by its solubilizing agent. Compare extraction conditions, check recovery in the soluble and insoluble fractions, and use reciprocal co-immunoprecipitation from an independent subunit. Treatment with a nuclease tests whether the association depends on DNA or RNA, but removal after extraction can itself destabilize a real nucleic-acid-dependent assembly. Purification from mixed tagged and untagged cell populations, with distinguishable stable isotope labeling, can test whether partners exchange after cell disruption. A reciprocal enrichment supports coassociation; demonstrating a direct contact still requires additional evidence.

For stoichiometry, raw mass spectrometry intensity is insufficient because different peptides have different digestion and ionization efficiencies. Use calibrated peptide standards or carefully normalized quantitative estimates, ideally with several reference subunits. native mass spectrometry measures intact assembly masses and can distinguish candidate subunit counts, while controlled dissociation helps assign subcomplexes. Bound lipids, post-translational modifications, gas-phase losses and heterogeneous occupancy complicate assignment, so check the mass against the summed masses of candidate subunits. Size-exclusion chromatography coupled to multi-angle light scattering independently constrains assembly mass, although an unresolved mixture produces an average and the hydrodynamic size alone is not a molecular mass. Quantitative mass spectrometry of protein complexes can combine interaction strengths, abundance and stoichiometry.^[ref]

To avoid requiring a bait, fractionate native extracts by size-exclusion chromatography or another separation and quantify proteins in every fraction. Correlated elution profiles suggest membership of the same protein complex; comparison across an independent separation helps distinguish coincidence. This co-fractionation mass spectrometry can also reveal shifts from a large assembly into smaller forms after treatment. It may merge different assemblies sharing a subunit, and a failure to coelute does not exclude a transient interaction. chemical cross-linking mass spectrometry adds spatial information: identify pairs of linked residues, translate them into distance restraints appropriate to the reagent and residue accessibility, and ask whether a proposed assembly can satisfy them. A cross-link is a proximity constraint, not automatically a permanent interface; intermolecular assignment is especially difficult for identical subunits.

In living biological cells, proximity labeling captures an interaction neighbourhood before disruptive extraction. A bait fused to TurboID marks nearby proteins with biotin, allowing stringent enrichment and mass spectrometry. The original TurboID work demonstrated useful labeling over roughly ten minutes, which is much faster than older long-labeling implementations.^[ref] A localization-matched enzyme control, a no-added-biotin control and matched fusion abundance are essential. The labeling pulse integrates both spatial proximity and residence time; ten-minute labeling cannot resolve a seconds-long interaction sequence. Changes in ATP, biotin availability, enzyme activity or access to reactive residues can change the labeling signal independently of complex membership. A pulse followed by a chase does not make the covalent label disappear when the partner leaves.

Structural methods distinguish alternative interpretations of these measurements. cryo-electron microscopy can assign ordered subunits, estimate occupancy of resolved features, and separate some compositionally different particle classes. Flexible or small subunits may remain invisible despite being present. X-ray crystallography resolves stable interfaces but selects material that crystallizes. Förster resonance energy transfer between appropriately positioned labels tests nanometre-scale proximity in intact biological cells; single-particle tracking and fluorescence correlation spectroscopy can test comobility and exchange. Label placement, spectral cross-talk and accidental colocalization require controls. None of these techniques by itself reliably inventories every component.

The computational analysis should preserve these distinctions. Construct a protein interaction network with separate edge types for copurification, cross-linking and proximity labeling. Cluster reproducibly supported associations to propose modules, distinguish a stable core from variable accessory components, and integrate localization and measured protein abundance. Models such as AlphaFold 3 can propose interfaces for experimentally supported candidate components, but a confident predicted geometry does not demonstrate that an interaction occurs in the tested condition.^[ref] Test interfaces by site-directed mutagenesis, confirming normal protein folding, expression and localization before interpreting a lost interaction. Evaluate a proposed assembly against independently held-out cross-links or other measurements to reduce circular validation.

For perturbations, use vehicle controls, several doses and early-to-late sampling; randomize preparation and instrument order. Quantify input abundance alongside bait-normalized partner recovery. An illustrative relative recruitment statistic for partner $i$ at time $t$ iswhere $I^{\mathrm{IP}}$ is background-corrected recovered intensity, $b$ is the bait and $A_i$ is input abundance. This is an operational comparison under matched extraction and measurement response, not an absolute occupancy or dissociation constant. A doubled recovered partner signal with doubled input abundance and unchanged bait recovery gives $R_i=1$, illustrating why raw enrichment alone would mislead. Values near the detection limit need uncertainty bounds rather than unstable ratios.

A drug-induced loss of several core components could mean disassembly, degradation, changed localization or poor recovery. Distinguish them with input proteomics, microscopy and native fractionation, then test reversibility after washout and rescue by a drug-resistant target when feasible. For stress, monitor viability and extraction-resistant material; for disease-associated mutations, compare otherwise matched genetic backgrounds and rescue with the normal allele. post-translational modifications may recruit an accessory partner without changing the core. hydrogen-deuterium exchange mass spectrometry can then test interface exposure, but its altered exchange reports accessibility and structural dynamics rather than a new subunit by itself. A convincing remodeling claim is a reproducible change in assembly membership or occupancy, separated from changes in abundance, localization and assay recovery, and connected to a functional consequence.

Engineering EPA or DHA production requires reconstruction of a coordinated lipid pathway, not simply adding an omega-3 desaturase. Conventional higher-plant oils already contain shorter omega-3 fatty acids such as alpha-linolenic acid; the missing trait is substantial synthesis and storage of particular long-chain products such as eicosapentaenoic acid and docosahexaenoic acid. The engineering problem includes enzyme compatibility, substrate trafficking, storage and fitness.

A representative aerobic route converts an 18-carbon precursor into a 20-carbon product through desaturation, elongation and a further desaturation. In shorthand, with $n$ denoting the omega family,A suitable elongation and $\Delta 4$ desaturation can extend this route to $22:6n-3$. Other organisms use different routes, so this sequence is a design choice rather than a universal algal pathway. Because elongation adds two carbons at the carboxyl end, the omega family can remain unchanged even though the carboxyl-based double-bond positions change. Gene selection must specify the actual substrate and product, not just an enzyme name.

The first obstacle is metabolic flux through a multi-enzyme pathway. An introduced fatty acid desaturase needs the correct substrate, electron supply, oxygen availability, membrane environment and intracellular location. A fatty acid elongase must work with the host's elongation machinery and access an appropriate acyl substrate. Early transgenic plant experiments demonstrated production of long-chain polyunsaturated products, establishing biochemical feasibility.^[ref] Accumulation of a product proves that a route can operate, but neither high transgene expression nor appearance of an intermediate establishes an adequate final yield.

A major problem is the substrate dichotomy between lipid-linked desaturation and acyl-CoA-dependent elongation. An introduced desaturase may act on a chain in phosphatidylcholine, whereas the next elongase requires that chain in the acyl-CoA pool. Poor exchange creates intermediate accumulation despite active enzymes. Experiments in transgenic oilseeds identified constraints involving desaturases, elongases and acyl transfer between these pools.^[ref] Possible engineering responses include choosing enzymes with compatible substrate-carrier preferences, improving acyl editing, or using an alternative order of reactions. These are different hypotheses and should be tested by measuring the actual molecular pools rather than only total fatty-acid percentages.

The pathway must also reach a useful destination. An unusual long-chain fatty acid made in a membrane lipid may fail to enter seed triacylglycerol. Host acyltransferases can discriminate among chain lengths and double-bond patterns, so storage can become limiting after biosynthesis is improved. Conversely, forcing too much unusual lipid into an essential membrane can disturb membrane protein function and seed development. Seed-specific expression and efficient transfer into lipid droplets can limit effects on vegetative tissues, but successful storage still requires coordination with the normal timing of seed oil accumulation.

Camelina sativa provided a proof of substantial engineered storage: different transgenic designs accumulated high levels of EPA or a combination of EPA and DHA in seed oils.^[ref] This shows that evolutionary absence is not a fundamental chemical prohibition. It does not establish that every variety, environment or production scale will give the same yield. Measure oil mass per seed, seed number, germination and field performance as well as fatty-acid composition. An illustrative crop yielding $1\mathrm{t}$ of oil per hectare at a target fraction of $0.20$ supplies $0.20\mathrm{t}$ of the target; raising that fraction to $0.25$ while halving oil yield gives only $0.125\mathrm{t}$. Fractional enrichment and agronomic productivity are different objectives.

Multi-gene expression creates additional constraints. Relative enzyme amounts matter, transgenes can segregate or become silenced, and excessive activity upstream can deplete precursors needed elsewhere. Stable inheritance and developmental timing must be verified over generations. Analyze independent lines and segregating controls, quantify enzyme activity where possible, and distinguish the intended product from structurally related intermediates. stable isotope labeling can reveal whether carbon is reaching a blocked intermediate or being diverted to another lipid class. Whole-seed measurements can conceal tissue-specific storage and transport limitations.

Evolutionary constraints have several levels. Closely related enzymes can differ substantially in substrate preference, while distantly related algal and plant proteins may require different electron partners or targeting signals. Sequence homology therefore guides selection but does not prove compatibility. Pathways have evolved together with their membrane composition, growth temperature and ecological niche; transferring one set of catalysts leaves the receiving plant's regulatory network and lipid-handling enzymes largely intact. Appropriate localization and balanced carrier pools may be as important as catalytic sequence changes.

Fitness costs are also plausible. Long-chain polyunsaturation can change membrane packing and increase susceptibility to lipid peroxidation, while synthesis consumes carbon and reducing power. A pathway beneficial in a marine microorganism may provide little reproductive advantage in a terrestrial seed plant, or may impose costs under heat, drought or oxidative stress. These are testable evolutionary hypotheses, not an established single explanation for the absence of EPA and DHA from conventional crop oils. Compare engineered and control plants across environments, measure oxidation products and fertility, and test whether storage-specific targeting reduces the cost.

The successful trait must combine a compatible biosynthetic route, exchange between lipid carriers, selective storage and acceptable reproductive performance. Evolution helps identify likely incompatibilities and tradeoffs, but the existence of productive engineered oilseeds shows why absence in an ancestral crop should not be mistaken for impossibility.

stable isotope labeling uses nonradioactive isotopes to distinguish molecular populations. Paired labeled and unlabeled samples can be compared by mass spectrometry, subject to labeling completeness, mixing and measurement-response controls.